CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.

CVS' Health Services segment posts $43B in revenues as specialty pharmacy and Caremark deals drive 2025 growth prospects.

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

CVS Caremark has been the PBM for the plan since Jan. 1, 2017. ... the plan estimated it received a 40% rebate from Novo Nordisk, the manufacturer of GLP-1s Wegovy and Saxenda.

CVS Caremark has been the PBM for the plan since Jan. 1, 2017. ... the plan estimated it received a 40% rebate from Novo Nordisk, the manufacturer of GLP-1s Wegovy and Saxenda.

The healthcare sector is dominated by massive players, but few are as influential as UnitedHealth Group Incorporated UNH and ...

More than 550 community pharmacies have closed across the commonwealth since January 2024, according to the Pennsylvania ...

The Treasurer's Office said in a news release Thursday that 18 months of contract negotiations have resulted in “an untenable impasse" with CVS Caremark, "which potentially endangers the ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, an ...